This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to naphthol, quinoline and isoquinoline-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
本发明涉及
辣椒素受体VR1
配体。更具体地说,本发明涉及
萘酚,
喹啉和
异喹啉衍生的
脲类化合物,它们是VR1的有效拮抗剂或激动剂,对哺乳动物的炎症和其他疼痛症状的治疗和预防有用。